Physician profile
Anna Hereth
NPI 1174074074
$517.37
in general payments reported to CMS, 2019-2025
7 companies · $97.14 in 2025
The $97.14 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $14.20 · 2023: $19.99 · 2024: $386 · 2025: $97.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $503.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $170.28 | 2024 | Ingrezza |
| Otsuka America Pharmaceutical, INC. | $134.61 | 2024-2025 | Rexulti |
| Axsome Therapeutics, INC. | $83.39 | 2024-2025 | Auvelity |
| Lundbeck LLC | $61.58 | 2023-2024 | Rexulti |
| Hologic Sales and Service, LLC | $39.07 | 2024 | Aptima |
| Takeda Pharmaceuticals U.S.A., INC. | $14.24 | 2024 | Trintellix |
| Abbvie INC. | $14.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Hereth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.